Initiating evaluation of composite outcome measures for psoriatic arthritis: 2022 updates from the GRAPPA-OMERACT Working Group

Benzer Materyaller

• GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies
  Yazar:: Tillett, W, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• The GRAPPA-OMERACT Working Group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates
  Yazar:: Leung, YY, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 annual meeting: report and plan for completing the core outcome measurement set
  Yazar:: Leung, Y, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Effect of secukinumab on the different GRAPPA-OMERACT core domains in psoriatic arthritis: a pooled analysis of 2049 patients
  Yazar:: Orbai, A-M, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative
  Yazar:: Antony, A, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)